Amo Pharma Limited
Clinical trials sponsored by Amo Pharma Limited, explained in plain language.
-
Drug trial tests hope for debilitating muscle disease in teens and adults
Disease control CompletedThis study tested whether a drug called Tideglusib is safe and helpful for adolescents and adults with a severe, early-onset form of myotonic dystrophy, a genetic muscle-wasting disease. Sixteen participants aged 12 to 45 took the drug to see if it could improve muscle function, …
Phase: PHASE2 • Sponsor: AMO Pharma Limited • Aim: Disease control
Last updated Apr 04, 2026 06:06 UTC
-
New drug tested to help kids with rare Muscle-Weakening disease
Disease control CompletedThis study tested whether a drug called tideglusib could improve symptoms in children and teenagers (ages 6-16) with congenital myotonic dystrophy, a rare genetic muscle disease. Participants were randomly assigned to receive either the active drug or a placebo (a dummy pill) for…
Phase: PHASE2, PHASE3 • Sponsor: AMO Pharma Limited • Aim: Disease control
Last updated Apr 04, 2026 06:05 UTC